Literature DB >> 10554768

Ovarian cancer antigen CA 125 enhances the invasiveness of the endometriotic cell line EEC 145.

R Gaetje1, D W Winnekendonk, A Scharl, M Kaufmann.   

Abstract

OBJECTIVE: Ovarian cancer antigen CA 125 is used widely for diagnostic and therapeutic evaluation of ovarian cancer. Although the initial description of CA 125 was in 1981, its function is still unknown. In collagen gel system the invasiveness of the endometriotic cell line EEC 145 is enhanced by a proteinaceous factor in peritoneal fluid mimicking molecular features of CA 125. Therefore we hypothesize that this factor is CA 125.
METHODS: The influence of heat-treated peritoneal fluid on the invasiveness of the endometriotic cell line EEC 145 and several human carcinoma cell lines (EJ28, RT112, AN3 CA, RL95-2, HEC-1-A, HeLa, MCF7, T-47D, and SK-OV-3) was investigated in a collagen gel invasion assay by addition of (1); 10% heat-treated peritoneal fluid, (2); peritoneal fluid after immunoprecipitation with antibodies directed to CA 125, and (3); purified CA 125.
RESULTS: The invasion index of the endometriotic cell line EEC 145 significantly increased from 4.78 +/- 0.98 to 6.57 +/- 1.58 (P = .0001) by addition of 10% heat-treated peritoneal fluid to the culture medium. The invasion-promoting effect of peritoneal fluid was abolished by reduction of the CA 125 concentration through immunoprecipitation and was mimicked in a dose-dependent manner by addition of CA 125 to the culture medium. The invasiveness of the investigated human carcinoma cell lines was not affected by heat-treated peritoneal fluid of CA 125.
CONCLUSION: The results are consistent with the hypothesis that CA 125 can influence invasiveness in a benign endometriotic cell line.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10554768     DOI: 10.1016/s1071-5576(99)00027-1

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  4 in total

1.  Elevated preoperative CA125 is associated with poor survival in patients with metastatic colorectal cancer undergoing primary tumor resection: a retrospective cohort study.

Authors:  Jun-Hua Huang; Hua-Shan Liu; Tuo Hu; Zong-Jin Zhang; Xiao-Wen He; Tai-Wei Mo; Xiao-Feng Wen; Ping Lan; Lei Lian; Xian-Rui Wu
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-06-14

2.  Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.

Authors:  M Comamala; M Pinard; C Thériault; I Matte; A Albert; M Boivin; J Beaudin; A Piché; C Rancourt
Journal:  Br J Cancer       Date:  2011-02-15       Impact factor: 7.640

3.  CA125/MUC16 is dispensable for mouse development and reproduction.

Authors:  Dong-Joo Cheon; Ying Wang; Jian Min Deng; Zhen Lu; Lianchun Xiao; Chun-Ming Chen; Robert C Bast; Richard R Behringer
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

4.  Exploring the glycosylation of serum CA125.

Authors:  Radka Saldova; Weston B Struwe; Kieran Wynne; Giuliano Elia; Michael J Duffy; Pauline M Rudd
Journal:  Int J Mol Sci       Date:  2013-07-26       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.